| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.003 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.18 | 0.004 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.005 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.005 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.098 | 0.005 |